These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5712734)

  • 21. Strain differences in the metabolism of imipramine by rat.
    Jori A; Bernardi D; Pugliatti C; Garattini S
    Biochem Pharmacol; 1970 Apr; 19(4):1315-21. PubMed ID: 5513922
    [No Abstract]   [Full Text] [Related]  

  • 22. N-oxidation of imipramine by isolated perfused rat and rabbit lung.
    Ohmiya Y; Mehendale HM
    Life Sci; 1980 Apr; 26(17):1411-21. PubMed ID: 7382724
    [No Abstract]   [Full Text] [Related]  

  • 23. Demethylation of imipramine and antitetrabenazine effect in the catalepsy and ptosis test.
    Michaelis W; Stille G
    Life Sci; 1968 Jan; 7(1):99-106. PubMed ID: 5636631
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of deuteration of imipramine on its pharmacokinetic properties in the rat.
    Taylor IW; Ioannides C; Sacra P; Turner JC; Parke DV
    Biochem Pharmacol; 1983 Feb; 32(4):641-7. PubMed ID: 6830627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of SKF 525-A on the excretion of amine oxides by the rat.
    Dehner EW; Machinist JM; Ziegler DM
    Life Sci; 1968 Nov; 7(21):1135-46. PubMed ID: 5712725
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasma imipramine levels and demethylase activity in the liver of stressed animals.
    Krulík R; Farská I; Jindrová O
    Neuropsychobiology; 1981; 7(1):12-6. PubMed ID: 7465017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional distribution and elimination kinetics of imipramine in rat brain after a single intraperitoneal administration.
    Masada M; Suzuki K; Kikuta S; Yamashita S; Nakanishi K; Nadai T; Igarashi Y; Noguchi T
    Chem Pharm Bull (Tokyo); 1986 May; 34(5):2173-7. PubMed ID: 3742657
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of diazepam, desmethylimipramine, and SKF 525-A on the disposition of levo-methadone in mice after single or double injection.
    Shah NS; Patel VO; Donald AG
    Drug Metab Dispos; 1979; 7(4):241-2. PubMed ID: 39728
    [No Abstract]   [Full Text] [Related]  

  • 29. The total fate of a drug: kinetics of distribution, excretion, and formation of 14 metabolites in rats treated with imipramine.
    Bickel MH; Weder HJ
    Arch Int Pharmacodyn Ther; 1968 Jun; 173(2):433-63. PubMed ID: 5684271
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the absorption and metabolism of imipramine by the rat brain after single and repeated doses].
    Schneider G; Schneider G
    Psychopharmacologia; 1969; 14(1):74-82. PubMed ID: 5361743
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter: Some factors modifying the metabolism of AH 8165 by rat liver homogenate in vitro.
    Srinivasan B; Wahdi C; Pleuvry B
    J Pharm Pharmacol; 1973 Aug; 25(8):657-8. PubMed ID: 4148439
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of 2-diethylaminoethyl-2,2-diphenylvalerate hydrochloride (SKF 525-A) on sulphacetamide distribution and excretion in rats.
    Marchand C; Nadeau D
    Br J Pharmacol; 1973 Jan; 47(1):69-76. PubMed ID: 4717021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of an inhibitor of hepatic drug metabolism, 2-diethylaminoethyl-2,2-diphenylvalerate HCl (SKF 525-A), on thyroxine metabolism in the rat.
    Nakamura Y; Bellamy G; Green WL
    Endocrinology; 1981 Apr; 108(4):1519-36. PubMed ID: 7472282
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of adrenalectomy and corticosterone on [3H]imipramine binding in rat blood platelets and brain.
    Arora RC; Meltzer HY
    Eur J Pharmacol; 1986 Apr; 123(3):415-9. PubMed ID: 3720826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of SKF 525A on the kinetics and action of an antivitamin K in the rat].
    Thonnart N; Letist D; Reuse J
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):369-72. PubMed ID: 4848952
    [No Abstract]   [Full Text] [Related]  

  • 36. Biotransformation and biliary excretion of imipramine in rats under various experimental conditions.
    Gigon PL
    Arch Int Pharmacodyn Ther; 1975 Aug; 216(2):315-27. PubMed ID: 1180619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The metabolism of imipramine and its metabolites by rat liver microsomes.
    Bickel MH; Baggiolini M
    Biochem Pharmacol; 1966 Aug; 15(8):1155-69. PubMed ID: 5973159
    [No Abstract]   [Full Text] [Related]  

  • 38. FAILURE OF IMIPRAMINE TO INFLUENCE SEROTONIN AND CATECHOLAMINE LEVELS IN THE SPECIFIC NEURONS OF RAT BRAIN.
    BARTONICEK V
    Med Pharmacol Exp Int J Exp Med; 1965; 12():395-8. PubMed ID: 14332244
    [No Abstract]   [Full Text] [Related]  

  • 39. On the metabolism of imipramine (Tofanil) in rat brain after single or repeated injections.
    Schneider G; Schneider G
    Ger Med Mon; 1968 Nov; 13(11):543-4. PubMed ID: 5720270
    [No Abstract]   [Full Text] [Related]  

  • 40. Measurement and pharmacokinetic analysis of imipramine and its metabolite by brain microdialysis.
    Sato Y; Shibanoki S; Sugahara M; Ishikawa K
    Br J Pharmacol; 1994 Jun; 112(2):625-9. PubMed ID: 8075879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.